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Abstract
Development of multiple sclerosis (MS) is more prevalent in females than in males, but the underlying mechanisms are not
clear. Microbial infections have been suspected as triggers of MS and it is not known whether gender differences in reactivity to environmental antigens contribute to the disease pathogenesis. We demonstrated that ACA 83–95, a mimicry epitope
from Acanthamoeba castellanii for proteolipid protein (PLP) 139–151, induces clinical signs of encephalomyelitis in both male
and female SJL mice. Conversely ACA 83–95-induced effector cells from males fail to induce disease in female mice. Although
we found no gender differences in the frequencies of antigen-specific cells including cytokine production, PLP-specific cells induced with ACA 83–95 differed in T cell receptor vβ usage from those induced with PLP 139–151. The data suggest that crossreactive T cell expansion occurs similarly in both males and females, but their disease-inducing ability is influenced by gender.
Keywords: Experimental autoimmune encephalomyelitis, multiple sclerosis, molecular mimicry, proteolipid protein, acanthamoeba castellanii, gender disparity

1. Introduction

ics have been shown to induce CNS inflammation through the
generation of cross-reactive T cells in an adjuvant protocol of experimental autoimmune encephalomyelitis (EAE) (Sospedra and
Martin, 2005).
EAE can be induced in mice with whole myelin proteins or
their peptides, such as MBPAc 1–11, MOG 35–55 and PLP 139–
151, and the disease is primarily mediated by CD4 T cells. MBP
Ac 1–11 induces the monophasic form of EAE in B10.PL or PL/J
(IAu) mice; MOG 35–55 induces the chronic progressive form
in C57BL/6 (IAb) mice; and PLP 139–151 induces relapsing–remitting paralysis in SJL (IAs) mice (Miller and Karpus, 2007).
These phenotypes resemble some of the clinical features of MS,
making observations in mice relevant to humans. Gender bias
in susceptibility to EAE exists for all of the above Ag, except for
MOG 35–55-induced EAE in C57BL/6 mice (Okuda et al., 2002),
suggesting that gender differences vary depending on the type
of Ag or genetic backgrounds.
Our studies involve PLP 139–151-induced EAE in SJL mice.
While both male and female mice develop PLP-induced EAE
with equal severity, relapses occur only with females, and the
disease is restricted to the monophasic form in males (Bebo et
al., 1996). We recently identified a mimicry epitope from Acanthamoeba castellanii (A. castellanii), called ACA 83–95, that induces autoimmune encephalomyelitis by generating T cells that
cross-react with PLP 139–151 (Massilamany et al., 2010). Using
ACA 83–95 as a test antigen, we addressed the hypothesis that
CNS autoimmunity induced by cross-reactive environmental Ag
differs by gender. We provide evidence that in response to ACA
83–95 both male and female SJL mice generate similar frequen-

Epidemiological data indicate that a number of autoimmune
diseases are more prevalent in females than in males. These include systemic lupus erythematosus (9 to 13:1), Sjogren’s syndrome (9:1), myasthenia gravis (2 to 14:1), scleroderma (3 to
4:1), Hashimoto’s thyroiditis (3:1), multiple sclerosis (MS) (2 to
3:1), and rheumatoid arthritis (2:1) (Ahmed et al., 1999; Beeson, 1994; Lockshin, 2001; Whitacre, 2001). MS is a chronic
demyelinating disease of the central nervous system (CNS).
The disease severity in female patients is reduced during pregnancy, but the symptoms of MS return to their pre-pregnant
state within six months post-delivery (Confavreux et al., 1998).
Such an alteration in the disease course is attributed to elevated amounts of T helper (Th) 2 cytokines during pregnancy.
In contrast, men are less likely to develop MS than women, but
they tend to develop a more severe, chronic form of the disease
(Compston et al., 1998) and the underlying mechanisms are
unknown.
Three major myelin antigens (Ag), namely proteolipid protein (PLP), myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG), have been identified as candidate
autoantigens in MS pathogenesis. Healthy humans carry myelin-reactive cells in their naïve periphery, but CNS autoimmunity does not occur spontaneously. How this tolerance is maintained is a fundamental question. It has been suggested that
the environmental Ag that bear structural similarities to selfAg break self-tolerance by cross-reactivity. This is the basis for
the molecular mimicry hypothesis, and several microbial mim95
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2. Materials and methods

ratories, Detroit, MI) was added as an additional component to
a final concentration of 5 mg/ml. Pertussis toxin (PT) (List Biological Laboratories, Campbell, CA) was administered (100 ng
per mouse) i.p. on day 0 and day 2 postimmunization.

2.1. Mice

2.3. Induction of adoptive transfer EAE (AT-EAE)

Five-to-six-week-old male and female SJL/J (H-2s) mice were
obtained from the Jackson Laboratory (Bar Harbor, ME). The
mice were maintained in accordance with the animal protocol
guidelines of the University of Nebraska-Lincoln, Lincoln, NE.

Groups of mice were immunized with 100 μg of either PLP
139–151 or ACA 83–95 per mouse. After ten days, mice were
killed and the inguinal, axillary, cervical, maxillary, and mandibular draining lymph nodes (LN) were harvested, and single cell suspensions were prepared after lysing the erythrocytes
with 1 × ammonium chloride potassium buffer (Lonza, Walkersville, MD). Lymph node cells (LNC) were stimulated with peptides (20 μg/ml) and rested for 14 days in medium containing
interleukin (IL)-2. The cells were restimulated with PLP 139–
151 or ACA 83–95 (20 μg/ml) in the presence of syngeneic antigen-presenting cells for two days, and the cultures were maintained in IL-2 medium. Viable lymphoblasts were harvested on
day 4 postimulation by Ficoll-hypaque density gradient centrifugation, and groups of naive male and female SJL mice were injected i.p. with 10 × 106 cells per mouse (Whitham et al., 1991).
PT (100 ng) was administered i.p. on days 0 and 2 posttransfer
and the disease was scored.

2.2. Peptide synthesis and immunization procedures
PLP 139–151 (HSLGKWLGHPDKF), ACA 83–95 (YFLLKWLGHPNVS) and neuraminidase (NASE) 101–120 (EALVRQGLAKVAYVYKPNNT) were synthesized on 9-fluorenylmethyloxycarbonyl chemistry (Neopeptide, Cambridge, MA). All peptides
were HPLC-purified (> 90%), identity was confirmed by mass
spectroscopy, and the peptides were dissolved in 1 × PBS. To
measure recall responses, peptides were emulsified in complete
Freund’s adjuvant (CFA) and administered s.c. in multiple sites
in the flank and sternum (100 μg per mouse). For disease induction, Mycobacterium tuberculosis H37RA extract (Difco Labo-

Figure 1. Gender differences in the susceptibility to autoimmune encephalomyelitis induced with ACA 83–95. (a) EAE induction by active immunization.
Groups of male and female SJL mice were immunized with PLP 139–151 or ACA 83–95 in CFA s.c., and PT was administered i.p. on day 0 and day 2 postimmunization. The mice were monitored for signs of EAE and scored (i), and the cumulative scores obtained by adding the scores from each mouse in a group
were compared between different groups (ii). Data represent mean ± SEM values of four individual experiments and in one experiment, animals were not
scored from days 24 to 26. (b) EAE induction by adoptive transfer. Short-term T cell lines were derived from male and female SJL mice immunized with PLP
139–151 or ACA 83–95 as described in methods. Viable lymphoblasts were harvested on day 4 and administered into naïve recipients i.p., and PT was given
i.p. on day 0 and day 2 posttransfer. The mice were monitored for clinical signs of EAE and scored (PLP groups, n = 3 to 6; ACA groups, n = 5–6).
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Table 1. Clinical and histologic EAE in SJL male and female mice induced with PLP 139–151 and ACA 83–95. (Numbers are mean ± SEM.)
Treatment

Clinical disease 		

No. of inflammatory foci

Incidence (%) Mean day of onset* Mean maximum score*

Meninges

Parenchyma

PLP 139–151						
Males
29/30 (96.6)
12.34 ± 0.29
2.86 ± 0.18
48.03 ± 9.54
23.50 ± 6.44
Females
27/29 (93.1)
13.59 ± 0.61
3.19 ± 0.15
75.62 ± 9.88
34.83 ± 6.71
p values				
2.89E−10
2.59E−05
ACA 83–95						
Males
34/40 (85.0)
11.56 ± 0.28
1.91 ± 0.13
8.63 ± 2.92
5.83 ± 2.32
Female
32/38 (84.2)
11.56 ± 0.62
2.59 ± 0.18
19.71 ± 4.94
12.37 ± 4.34
p values				
2.06E−06
2.34E−04

Total
71.23 ± 15.56
112.69 ± 16.07
4.84E−11
14.38 ± 5.17
32.37 ± 8.92
4.54E−07

Scoring scale: 0, healthy; 1, limp tail or hind limb weakness but not both; 2, limp tail and hind limb weakness; 3, partial paralysis of hind limbs; 4, complete
paralysis of hind limbs; 5, moribund or dead.
* Represents only mice that showed clinical disease.

2.4. Clinical scoring and histopathology
Following EAE induction, the mice were monitored for clinical signs of disease and scored as described previously (Tuohy
et al., 1989): 0 – healthy; 1 – limp tail or hind limb weakness but
not both; 2 – limp tail and hind limb weakness; 3 – partial paralysis of hind limbs; 4 – complete paralysis of hind limbs; 5 –
moribund or dead. The neurological scores obtained from each
mouse in a group were added to obtain cumulative scores and
compared between groups. Animals were euthanized upon termination and brain and spinal cords were collected in 10% phosphate buffered formalin and analyzed for histological evidence
of the disease (Massilamany et al., 2010; Sobel et al., 1990). After fixation, brain sections were made through the cerebrum,
hippocampus, cerebellum, and brainstem. In the spinal cord,
the cervical, thoracic, lumbar, and sacral regions were each made
into three sections, and the tissues were stained by Hematoxylin and Eosin staining. Tissues were blinded to treatment and
scored for lesion type and severity and counts were added together. Total scores were obtained by adding counts of inflammatory foci in both meninges and parenchyma. Inflammation
was primarily classified as lymphocytic, suppurative, or mixed
(Massilamany et al., 2010).
2.5. T cell proliferation assay

were stained with anti-CD4 and 7-amino-actinomycin-D (7AAD) (Invitrogen, Eugene, OR) and acquired by flow cytometer
(FACS Scan, BD Pharmingen, San Diego, CA). The frequency of
tetramer+ (tet+) cells was then enumerated using Flow Jo software (Tree Star, Ashland, OR) in a live (7-AAD−) CD4+ population. To determine the Ag specificity of cross-reactive T cell responses induced with PLP 139–151 and ACA 83–95, four-color
flow cytometric analysis was performed to include allophycocyanin (APC)-conjugated PLP 139–151- and ACA 83–95-PE tetramers, anti-CD4, and 7-AAD. Cells were acquired by FACS Calibur
(BD Pharmingen) and the frequency of tet+ cells was analyzed
using Flow Jo software in the live (7-AAD−) CD4+ subset.
2.7. Cytokine measurement
We measured the synthesis of IL-2, interferon (IFN)-γ, IL4, IL-10, IL-17A, IL-17F, IL-22, tumor necrosis factor (TNF)-α,
and granulocyte-macrophage colony-stimulating factor (GMCSF) by intracellular staining and/or cytokine ELISA. The frequency of cytokine-secreting cells was determined in LNC obtained from mice immunized with PLP 139–151 or ACA 83–95
by flow cytometry (Massilamany et al., 2010; Reddy et al.,
2004). Briefly, LNC were stimulated with peptides (20 μg/ml)
for two days and the cultures were maintained in IL-2 medium.
Viable lymphoblasts were harvested on day 5 and stimulated

Ten days after immunization with the indicated peptides,
mice were killed and the draining LN were harvested to obtain
single cell suspensions. LNC were stimulated with PLP 139–
151, ACA 83–95, and NASE 101–120 (control) at a cell density
of 5 × 106 cells/ml for two days in RPMI medium supplemented
with 10% fetal calf serum, 1 mM sodium pyruvate, 4 mM L-glutamine, 1 × each of non-essential amino acids and vitamin mixture, and 100 U/ml penicillin–streptomycin (Lonza). Cultures
were then pulsed with 1 μCi of tritiated 3[H] thymidine per well;
16 h later, proliferative responses were measured as counts per
minute (cpm) using the Wallac liquid scintillation counter (Perkin Elmer, Waltham, MA).
2.6. IAs tetramer staining
To determine the frequency of antigen-specific T cells, IAs/
PLP 139–151, ACA 83–95 and Theiler’s murine encephalomyelitis virus (TMEV) 70–86 tetramers were created as described
(Massilamany et al., 2010). LNC obtained from the mice immunized with PLP 139–151 or ACA 83–95 were stimulated with
the corresponding peptides (20 μg/ml) for six days. Viable lymphoblasts were incubated with phycoerythrin (PE)-conjugated
IAs tetramers (30 μg/ml) at room temperature for 3 h (Massilamany et al., 2010; Reddy et al., 2003). After washing twice, cells

Figure 2. ACA 83–95 induces PLP 139–151-reactive T cell responses equally
in both male and female SJL mice. Groups of male and female SJL mice were
immunized with PLP 139–151 or ACA 83–95 in CFA. Ten days later, the
mice were killed, LN were harvested, and single cell suspensions were prepared. LNC were stimulated with PLP 139–151, ACA 83–95, and NASE 101–
120 (control) for two days. Cells were then pulsed with tritiated 3[H] thymidine for 16 h, the incorporation of which was measured as cpm. Mean ± SEM
values for a group of mice are shown.
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Figure 3. Antigen-specificity of cross-reactive T cells induced with PLP 139–151 or ACA 83–95. (a) Antigen specificity. Male and female SJL mice were immunized with PLP 139–151 or ACA 83–95 in CFA. After ten days, mice were killed and LNC were prepared from the draining LN and stimulated with the indicated peptides. Viable lymphoblasts were harvested on day 6 poststimulation and stained with IAs/tetramers, namely PLP 139–151, ACA 83–95, and TMEV
70–86 (control), followed by staining with anti-CD4 and 7-AAD. Cells were acquired by flow cytometry and the percentages of tet+ cells were analyzed in the
live (7-AAD−) CD4 subset. (b) Detection of cross-reactive T cells by double tetramer staining. Cells from the above cultures were stained with PLP 139–151APC and ACA 83–95-PE tetramers, followed by staining with anti-CD4 and 7-AAD. After acquiring the cells by flow cytometry, double tet+ cells were analyzed
in the live (7-AAD−) CD4 subset.

for approximately 5 h with phorbol 12-myristate 13-acetate
(PMA) (10 ng/ml) and ionomycin (150 ng/ml) (Sigma-Aldrich,
St. Louis, MO) in the presence of monensin 2 mM (GolgiStop,
BD Pharmingen). After staining with anti-CD4 and 7-AAD, cells
were fixed, permeabilized and stained with cytokine antibodies
or isotype controls (eBioscience, San Diego, CA). The frequency
of cytokine-secreting cells was then determined in the live (7AAD−) CD4+ subset by flow cytometry (FACS Scan, BD Pharmingen). To estimate the frequency of cytokine-producing PLP
139–151-specific cells, lymphoblasts were first stained with PLP
139–151 tetramers, followed by staining with anti-CD4, 7-AAD
and cytokine antibodies, and the cells were acquired by flow cytometry. Frequencies of cytokine-producing PLP 139–151 tet+
cells were then determined in the live (7-AAD−) CD4 population using Flow Jo software. Culture supernatants harvested on

day 2 poststimulation with peptides were analyzed by cytokine
ELISA. The clones of antibodies used for cytokine measurement
were as previously published (Massilamany et al., 2010).
2.8. Analysis of T cell receptor (TCR) vβ usage
LNC obtained from the mice immunized with PLP 139–151 or
ACA 83–95 were stimulated with peptides for two days (20 μg/
ml) and maintained in medium containing IL-2 for five days.
Cells were stained with a panel of anti-mouse TCR vβ antibodies:
vβ 2, 3, 4, 5.1, 5.2, 6, 7, 8.1, 8.2, 8.3, 9, 10b, 11, 12, 13, 14 and
17a (BD Pharmingen), anti-CD4, and 7-AAD. After washing, cells
were acquired by flow cytometer and the percentages of TCR vβ+
cells were enumerated in the live (7-AAD−) CD4 population. To
determine the frequency of TCR vβ+ PLP 139–151-specific cells,
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Figure 4. ACA 83–95-induced PLP 139–151-reactive T cells produce similar patterns of cytokines in both male and female SJL mice. (a) Detection of cytokine-secreting cells by intracellular staining. Groups of male and female SJL mice were immunized with PLP 139–151 or ACA 83–95; the mice were killed ten
days later and LN were harvested to prepare single cell suspensions. LNC were stimulated with peptides for two days and the cultures were maintained in IL-2
medium. Viable lymphoblasts were harvested on day 5 poststimulation and stimulated with PMA and ionomycin for approximately 5 h, followed by staining with anti-CD4 and 7-AAD. After fixation and permeabilization, the cells were incubated with cytokine antibodies and the frequency of cytokine+ cells was
enumerated by flow cytometry in the live (7-AAD−) CD4+ T cells. Mean ± SEM values are shown (n = 4). (b) Cytokine ELISA. Cytokines in the supernatants
harvested on day 2 from the above cultures were determined by ELISA. (c) Enumeration of the frequency of cytokine-secreting PLP 139–151 tet+ cells. Viable lymphoblasts were harvested from peptide-stimulated cultures and the cells were first stained with PLP 139–151-APC tetramers followed by staining with
anti-CD4, 7-AAD and cytokine antibodies. After acquiring the cells by flow cytometry, percentages of cytokine-secreting PLP 139–151 tet+ cells were determined in the live CD4 subset. A representative from three individual experiments involving three mice in each group is shown.

100
Figure 5. TCR vβ usage in PLP 139–151-reactive
T cells generated in response to ACA 83–95 differs from PLP 139–151. (a) TCR vβ usage in CD4 T
cells. Groups of male and female SJL mice were immunized with PLP 139–151 or ACA 83–95; ten days
later, mice were killed and LN were harvested. LNC
were stimulated with peptides for two days and
maintained in IL-2 medium. Cells harvested on day
7 poststimulation were stained with a panel of antiTCR vβ and anti-CD4 and 7-AAD. After acquiring the
cells by flow cytometer, percentages of TCR vβ+CD4+
cells were determined in the live (7-AAD−) population. (b) TCR vβ usage in PLP 139–151 tet+ cells.
LNC cultures were prepared from the mice immunized with PLP 139–151 or ACA 83–95 as above. Viable lymphoblasts were harvested on day 7 poststimulation and stained with PLP 139–151 tetramers,
followed by anti-CD4, anti-TCR vβ and 7-AAD. Cells
were acquired by flow cytometer and the percentages
of TCR vβ+PLP 139–151 tet+ cells were determined
in the live (7-AAD−) CD4 subset.
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lymphocytes were stained first with PLP 139–151 tetramers, followed by anti-CD4 and 7-AAD (Greve et al., 2004). After the cells
were acquired by flow cytometry, the frequency of PLP 139–151
tet+ cells was enumerated in relation to TCR vβ expression in the
live (7-AAD−) CD4 subset using Flow Jo software.
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The Wilcoxon rank sum test was used to compare differences
in the severity of clinical and histological EAE induced with PLP
139–151 or ACA 83–95. Time-course analysis of clinical EAE induced by active immunization involved the use of median values
of clinical scores taken within individual animals for two time
periods, days 9–15 and days 1–30 postimmunization, and the
data were analyzed using Matlab software. Cumulative scores
for each animal within a group were obtained by adding the
scores of all the days and comparisons were then made between
groups. Gender differences in T cell proliferation, cytokine-secretion, and TCR vβ usage were analyzed by Student’s t. p ≤ 0.05
values were used to determine significance.

(score 0 to 1) during days 55 to 58 posttransfer. The disease phenotype produced with ACA 83–95-reactive T cells, in contrast to
PLP 139–151-reactive cells, differed in several aspects [Figure 1b
(ii)]. (a) Cells from females induced EAE in both genders with a
comparable severity (mean maximum scores: males, 3.5; females,
4.0), but the mean day of disease onset was delayed in male recipients (day 17.25) compared to female recipients (day 9.83). Relapses occurred in 83% (5/6) of females that received cells from
females. Likewise 40% (2/5) of males that received female cells
also showed relapses. Among these, one animal showed relapses
on two occasions, days 29–33 and 57–59 and both from scores 0
to 1. Another animal showed a relapse with a score from 1 to 2
during days 35–38. (b) Cells from males could induce disease in
only 40% (2/5) of male recipients, the onset of which occurred on
day 18.5 posttransfer, and one of them showed relapses; however,
these cells failed to induce EAE in female recipients. Together the
data suggest both male and female SJL mice are equally susceptible to EAE induced with ACA 83–95 by active immunization,
but the effector cells generated in males are less encephalitogenic
than those generated in their female counterparts.

3. Results

3.2. Male and female SJL mice respond equally to ACA 83–95

3.1. ACA 83–95 induces autoimmune encephalomyelitis in
both male and female SJL mice by active immunization, but
the effector cells generated in males are less pathogenic than
those generated in females

Groups of male and female SJL mice were immunized with
ACA 83–95 or PLP 139–151, and ten days later, recall responses
were measured based on tritiated 3[H] thymidine incorporation
using NASE 101–120 as a negative control (Figure 2). ACA 83–95
and PLP 139–151 induced T cell responses of a similar magnitude
in both males and females in a dose-dependent manner, and a proportion of this response was also attributed to the generation of
T cells that cross-react with unimmunizing peptides. That is, the
mice immunized with PLP 139–151 showed proliferative response
to ACA 83–95, and vice versa, and the T cell responses were specific, since there was no response to NASE 101–120 (Figure 2).

2.9. Statistics

We used active immunization and AT-EAE protocols to determine gender differences in the susceptibility to autoimmune encephalomyelitis induced with ACA 83–95. These protocols involved PLP 139–151-induced EAE as a positive control system
to which the disease phenotype of ACA 83–95 was compared. As
shown in Figure 1a, both PLP 139–151 and ACA 83–95 induced
clinical signs of EAE in male and female SJL mice. Although clinical signs induced by both peptides were identical, the disease onset occurred relatively earlier with ACA 83–95 (males and females:
11.56) than with PLP 139–151 (males, 12.34; females, 13.59) (Table 1). Time-course comparison of clinical EAE revealed that the
EAE severity induced with ACA 83–95 was significantly lower
than that induced with PLP 139–151 in both males (mean maximum scores: 1.91 vs. 2.86; p = 2.94E−05) and females (mean maximum scores: 2.59 vs. 3.19; p = 3.49E−05) ( Table 1). These differences were also confirmed by comparing the cumulative scores
between groups [ Figure 1a (ii)]. EAE severity induced with ACA
83–95 was significantly greater in female mice during peaking of
disease (9–15 days postimmunization) than in males (p = 0.022)
( Figure 1a). Histologically, inflammatory infiltrates comprising
predominantly mononuclear cells were also significantly higher in
the brains and spinal cords of females than in males, regardless of
immunogens used ( Table 1).
We next studied gender-biased differences in the adoptive
transfer system by administering ACA 83–95-stimulated cells into
naïve recipients and comparing the disease severity with mice in
which EAE was induced with PLP 139–151-reactive cells. This was
to better discern gender-disparity in T cell functions at the level
of the effector phase. Figure 1b (i) shows that PLP 139–151-reactive cells from males and females induced EAE with a comparable
severity when cells were transferred into their corresponding genders and also into opposite sexes in criss-cross experiments, with
one exception. That is, PLP-reactive T cells generated in males induced relatively mild disease in females (mean maximum scores: 4
vs. 5), and the mean day of disease-onset was delayed (male cells
to males: day 9.33; male cells to females: day 30). One of the four
female mice (25%) that received male cells showed a mild relapse

3.3. ACA 83–95 induces similar frequencies of cross-reactive
T cells in both male and female SJL mice
We determined antigen specificity and the precursor frequency
of cross-reactive T cells induced with PLP 139–151 and ACA 83–
95 by flow cytometry using IAs/tetramers for PLP 139–151 and
ACA 83–95 (Figure 3). LNC from mice immunized with ACA 83–
95 and PLP 139–151 were restimulated with corresponding peptides and the cultures were maintained in IL-2 medium. Lymphoblasts harvested on day 6 poststimulation were used for tetramer
staining. In all of the staining reactions, TMEV 70–86 tetramers
were used as negative controls, for which there was negligible
binding in cultures stimulated with PLP 139–151 or ACA 83–95
(Figure 3a). Tetramer analysis indicated that in mice immunized
with PLP 139–151, PLP-reactive T cells expanded with comparable proportions in both males (1.87%) and females (2.21%), and
a subset of CD4 T cells also stained with ACA 83–95 tetramers
expanded proportionally (males, 1.09%; females, 1.11%) (Figure 3a). In a similar analysis with ACA 83–95-immunized mice,
it was found that males tended to respond relatively better to
ACA 83–95 than females, and the percentages of ACA tet+ cells in
male and female mice were estimated to be 9.28% and 6.32%, respectively. Importantly, CD4 T cells from ACA 83–95-immunized
mice also bind to PLP 139–151 tetramers, and the frequency of
PLP tet+ cells tended to be higher in males (1.90%) than females
(1.45%) (Figure 3a). We further verified the precursor frequencies of cross-reactive T cells by double tetramer staining using PLP
139–151 and ACA 83–95 tetramers (Figure 3b). First, we compared the frequencies of total PLP 139–151-specific T cells generated in response to PLP 139–151 and ACA 83–95 by combining
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the percentages of CD4 T cells that bind to PLP 139–151 tetramers alone (upper left quadrant, Figure 3b) and those that bind to
both PLP 139–151 and ACA 83–95 tetramers (upper right quadrant, Figure 3b). The mice immunized with PLP 139–151 showed
two-fold increase in the proportion of PLP-reactive T cells (males,
2.54%; females, 2.72%) over those immunized with ACA 83–95
(males, 1.42%; females, 1.16%). Second, we estimated the frequency of cross-reactive T cells that bind to both PLP 139–151
and ACA 83–95 tetramers; the frequency was higher in mice immunized with ACA 83–95 (males, 0.83%; females, 0.60%) than in
PLP 139–151-immunized mice (males, 0.33%; females, 0.45%)
(Figure 3b). The tetramer analysis thus enabled us to conclude
that ACA 83–95 is relatively more immunogenic in males than in
females, which might have allowed the males to generate a marginally greater number of cross-reactive T cells than females.
3.4. Cytokine production in ACA 83–95-induced PLP
139–151-reactive T cells does not differ by gender
We measured cytokines as readouts to determine the pathogenicity of effector cells induced with PLP 139–151 and ACA
83–95 (Figure 4). Cytokine secretion was measured in LNC cultures obtained from mice immunized with the corresponding peptides by intracellular staining and cytokine ELISA using a panel of Th1 (IL-2 and IFN-γ), Th2 (IL-4 and IL-10), Th17
(IL-17A, IL-17F, and IL-22) and other inflammatory cytokines,
namely, TNF-α and GM-CSF. As shown in Figure 4a, CD4 T cells
capable of secreting both Th1 and Th17 cytokines were dominant in cultures stimulated with ACA 83–95 or PLP 139–151,
but there were no significant gender differences in the secretion
of any of the cytokines tested. Similar patterns were also noted
when cytokines were analyzed by ELISA (Figure 4b). Gender differences in the ability to secrete IFN-γ and IL-17 were further
verified at a single cell level in PLP-specific T cell populations by
using PLP 139–151 tetramers. We calculated the percentages of
cytokine-producing PLP tet+ cells using the formula: frequencies of cytokine+tet+ cells (upper right quadrant)/[frequencies of
cytokine+tet+ cells (upper right quadrant) + frequencies of cytokine−tet+ cells (upper left quadrant)] × 100 (Figure 4c). The tetramer analysis indicated that the frequencies of PLP tet+ cells
capable of producing IFN-γ did not differ between genders, regardless of the immunogens used (PLP 139–151: males,13.02%;
females, 12.31%; ACA 83–95: males, 13.38%; females, 14.05%)
On the contrary, frequencies of IL-17-secreting PLP tet+ cells
tended to be higher in males than females (PLP 139–151: males,
13.85%; females, 8.55%; ACA 83–95: males, 10.61%; females,
7.26%). Collectively, the data indicate that both male and female
mice can generate pathogenic cross-reactive T cells in response
to ACA 83–95, suggesting that these cells have a potential to induce CNS inflammation regardless of their gender origin.
3.5. TCR vβ usage differs in PLP 139–151-reactive T cells induced with ACA 83–95 and those induced with PLP 139–151
To determine whether effector cells induced with PLP 139–
151 and ACA 83–95 use similar or alternate TCR vβs, we analyzed
their surface expression in LNC cultures derived from male and
female mice immunized with PLP 139–151 or ACA 83–95. Lymphoblasts harvested on day 7 poststimulation were used for analysis by flow cytometry (Figure 5a). In cultures stimulated with
PLP 139–151 or ACA 83–95, expression of TCR vβ2, vβ17a, vβ4,
vβ14, vβ6 and vβ3 occurred predominantly but in a decreasing
order and together represented 65% of the total CD4 cell population (Figure 5a). TCR vβ2 was expressed significantly more in ACA
83–95-stimulated cultures (males, p = 0.004; females, p = 0.0001)
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than in PLP 139–151-stimulated cultures, with a corresponding
decrease in TCR vβ17a (males, p = 0.0006; females, p = 0.0002).
Likewise, TCR vβ14 expression was also marginally more in ACA
83–95-stimulated cells than in cells stimulated with PLP 139–151
in males (p = 0.056). We verified these differences and confirmed
antigen-specificity of cross-reactive cells by tetramer analysis. We
calculated the percentages of TCR vβ-expressing PLP-specific cells
using the following formula: frequencies of vβ+tet+ cells (upper
right quadrant)/[frequencies of vβ+tet+ cells (upper right quadrant) + frequencies of Vβ−tet+ cells (upper left quadrant)] × 100 (
Figure 5b). PLP 139−151 tet+ cells generated with both PLP 139–
151 and ACA 83–95 immunizations contained T cells expressing all of the above TCR vβs, but tetramer analysis revealed a few
differences ( Figure 5b and Table 2). (a) TCR vβ2 was expressed
more in PLP tet+ cells generated by ACA 83–95 in both males
(p = 0.058) and females (p = 0.026), but frequencies of PLP tet+
cells expressing TCR vβ17a did not differ. (b) While TCR vβ3 expression was insignificant in PLP tet+ cells, TCR vβ14+ PLP tet+
cells tended to be higher in cells stimulated with ACA 83–95 than
PLP 139–151-stimulated cells within males (p = 0.067). (c) PLP
tet+ cells from female mice immunized with PLP 139–151 showed
a marginal increase in the expression of TCR vβ6 as compared
with males (p = 0.06). Overall, the expression pattern of TCR vβ
usage revealed no gender differences, but PLP–specific cells induced with ACA 83–95 utilize different pattern of TCR vβs as opposed to those induced with PLP 139–151, raising the question
whether such variations contribute to disease susceptibility.
4. Discussion
By using ACA 83–95, we investigated whether disparity in
T cell reactivity to microbial mimics contributes to gender differences in CNS autoimmunity in SJL mice. Our data revealed
that ACA 83–95-induced EAE was less severe in males than in
females clinically (Figure 1a) and histologically (Table 1). In
AT-EAE, we noted that PLP-reactive T cells obtained from female mice induced EAE with equal severity in both genders,
whereas cells from males induced relatively mild EAE in females,
the onset of which was significantly prolonged [Figure 1b (i)].
These data are consistent with the findings of others (Bebo et
al., 1996, 1998; Voskuhl et al., 1996). In contrast, gender disparity was more pronounced with the disease produced by ACA
83–95-stimulated cells. First, cells from female mice induced
EAE in both male and female recipients [Figure 1b (ii)]. Second,
cells from males induced only mild EAE in male recipients, but
they failed to induce disease in female recipients. These findings indicate that sex of both the donor and the recipient are
critical for EAE induction with cross-reactive microbial Ag. Alternatively, the inherent ability of males to resist the development of EAE could explain the occurrence of a mild form of the
disease in them. But it is hard to explain why females receiving
male cells stimulated with ACA 83–95 did not develop EAE. To
Table 2. Analysis of TCR vβ-expressing PLP 139–151 tetramer+ cells.
Immunized groupsa

TCR vβ

		 PLP 139–151 		
Male
vβ2
vβ3
vβ4
vβ6
vβ14
vβ17a

3.76b

11.78 ±
2.38 ± 0.26
13.25 ± 1.44
3.90 ± 0.15d
3.42 ± 0.35e
11.51 ± 1.24

Female
2.98c

10.61 ±
2.18 ± 0.74
11.43 ± 0.86
4.93 ± 0.37d
4.22 ± 0.16
11.14 ± 1.35

ACA 83–95
Male

Female

17.33 ±
18.06 ± 2.27c
10.02 ± 5.42
4.32 ± 1.35
10.76 ± 4.12 15.66 ± 2.28
6.06 ± 2.58
5.04 ± 0.61
5.13 ± 0.40e 3.93 ± 0.78
9.52 ± 3.00
8.00 ± 1.47

a. n = 3 each involving 2 to 3 mice per group.
b: p = 0.058 ; c: p = 0.026 ; d: p = 0.061 ; e: p = 0.067

1.63b

Gender
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CNS
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explain these differences, we investigated whether variations in
the generation of the frequencies of antigen-specific cells, cytokine secretion and TCR vβ usage in effector cells contribute to
gender-disparity in EAE induced by ACA 83–95.
Induction of EAE by active immunization with myelin Ag
first involves the generation of encephalitogenic T cells in the
periphery followed by their migration into the CNS, which then
mediates the inflammatory process. We verified that T cell responses of male and female SJL mice to both Ag were similar,
including the magnitude, dose–response patterns, and crossreactivity (Figure 2). We confirmed these findings by tetramer
analysis, which indicated that the frequency of total number of
PLP tet+ cells generated in response to ACA 83–95-immunization was two-fold lower than the frequency obtained with PLP
139–151, regardless of gender (Figure 3b). This may be the reason ACA 83–95-induced EAE was less severe than EAE induced
by PLP 139–151. However, if gender bias exists at all, male mice
immunized with ACA 83–95 have a tendency to generate more
PLP 139–151-reactive T cells, as assessed by using PLP 139–
151 tetramers alone (Figure 3a) or a combination of both PLP
139–151 and ACA 83–95 tetramers to determine double tet+
cells that represent cross-reactive T cell populations (Figure 3b).
Therefore logically, ACA 83–95-induced PLP-reactive cells from
males are expected to produce disease similar to that produced
by female cells, but this was not the case. By analyzing cytokine
production, we noted that Th1 and Th17 cytokine-producing
cells were dominant in cultures stimulated with PLP 139–151
or ACA 83–95, with a tendency for males to show a higher frequency of IL-17-secreting cells than females (Figure 4). Therefore, we think that variation in cytokine synthesis in male mice
was also not a contributing factor in their development of a mild
EAE phenotype. Taken together, our data suggest that both
male and female mice respond equally to ACA 83–95 and generate similar frequencies of pathogenic cells, while the effector
cells from males but not females lose their encephalitogenicity.
We then asked whether inherent variations in the encephalitogenicity of PLP-reactive T cells induced with cognate (PLP
139–151) and mimicry (ACA 83–95) epitopes in males and females were due to differences in TCR vβ usage. It has been
shown that the pathogenic T cell repertoires induced by PLP
139–151 are heterogenic in which TCR vβ2, 4, 6, 7, 14, and 17a
are predominantly expressed (Kuchroo et al., 1992, 1994). Since
the encephalitogenicity was weaker in effector cells induced by
ACA 83–95 than in those induced by PLP 139–151, we asked
whether ACA 83–95-induced effector cells use alternate TCRs
such that the newly generated T cell clones are weakly encephalitogenic. We addressed this possibility by using PLP 139–151
tetramers. Although there were no gender differences, we noted
that PLP 139–151 tet+ cells expressing TCR vβ2 were skewed
in LNC cultures from mice immunized with ACA 83–95 with
no significant variations in the other vβs (Table 2). Previously
it was shown that spinal cord infiltrates from PLP 139–151-induced EAE in SJL mice predominantly express TCR vβ2 and vβ
17a (Bebo et al., 1996). The fact that ACA 83–95-induced EAE
was less severe than EAE induced by PLP 139–151 in both genders in spite of significant increase in vβ2-expressing cells suggests that they are not the major mediators of disease; rather,
multiple T cell clones expressing heterogeneous TCR vβ chains
are critical for disease induction by ACA 83–95.
Several factors contribute to gender bias in susceptibility to
EAE. These include sex hormones, immune deviation, and functional disparity in antigen-presenting cells (Bebo et al., 1996,
2001; Offner, 2004; Voskuhl and Palaszynski, 2001). We previously demonstrated that regulatory T (Treg) cells mediate genetic resistance to the development of EAE in B10.S (H-2s) mice

(Reddy et al., 2005). We had proposed that males have a capacity to generate potent autoreactive T cells but their expansion is
kept in check by Treg cells. Once this check point is released, autoreactive T cells freely expand and induce CNS inflammation.
Whether a similar mechanism contributes to the reduced pathogenic potential of cross-reactive T cells induced by microbial
products in males remains to be tested.
In summary, we show that both males and females generate similar frequencies of cross-reactive T cells for PLP, but their
pathogenicity differs by gender during the effector phase of
EAE induction. In contrast to PLP-reactive T cells obtained with
PLP 139–151, encephalitogenicity of ACA 83–95-induced effector cells in males was weak, implying that environmental exposure to mimicry peptides can lead to the generation of more potent autoaggressive cells in females than in males. A. castellanii
is a natural CNS pathogen of humans and the amoeba can induce encephalitis in infected mice; both mouse and human isolates of amoebae can induce histologically similar disease ( Culbertson et al., 1959, Culbertson et al., 1958 and Marciano-Cabral
and Cabral, 2003). This infection model can therefore be used to
address gender-biased differences in the generation of autoreactive T cells and their ability to induce CNS autoimmunity.
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